1CM Inc. (CNSX: EPIC)
Health Care · Pharmaceuticals · CA
CA$0.18
— today · -60.4% 1Y
1CM Inc. (CNSX: EPIC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.85M and employs 11 people.
Over the last twelve months the share price has lost 60.4%, trading between 0.09 and 0.50.
Tweenvest scores 1CM Inc. across four factors: quality 62/100, value 45/100, growth 100/100. Its strongest factor is growth.
EPIC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.85M
- Revenue (TTM)
- $54.73M
- P/E
- 4.46
- EPS
- 0.04
- Dividend yield
- —
- Beta (5Y)
- 1.98
- 52-week high
- CA$0.50
- 52-week low
- CA$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 117.74M
- Employees
- 11
- Next earnings
- —
About 1CM Inc.
1CM Inc. functions as a diverse enterprise within the cannabis industry. The company's primary focus is on utilizing technology to cater to individual consumers, with the objective of making cannabis markets more accessible and inclusive. Previously known as Leviathan Natural Products Inc., the company underwent a name change to 1CM Inc. in September 2022. Its operations are headquartered in Markham, Canada.
- ISIN
- CA68237A1093
- Listed since
- Feb 22, 2012
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bal Pharma LimitedBSE: 524824 | $15.32M | Rs93.15 | -11.79% |
| Auro Laboratories LimitedBSE: 530233 | $15.24M | Rs236.60 | -2.95% |
| PeterLabs Holdings BerhadKLSE: PLABS | $15.16M | RM0.23 | +2.27% |
| Par Drugs and Chemicals LimitedNSEI: PAR | $14.89M | Rs117.10 | -5.53% |
| Thalia Therapeutics PlcAIM: THAT | $14.69M | £0.01 | -0.80% |
| Vyome Holdings, Inc.NasdaqCM: HIND | $14.67M | $2.09 | +9.42% |
| Ambee Pharmaceuticals PLCDSE: AMBEEPHA | $14.65M | Tk752.00 | +1.43% |
| Godavari Drugs LimitedBSE: 530317 | $14.65M | Rs140.00 | +18.59% |
Figures last refreshed Oct 11, 2026.